MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AXGN — Axogen, Inc. Common Stock
NasdaqAxogen, Inc. Common Stock
$37.39
-2.53(-6.34%)
- O
- 39.92
- H
- 39.92
- L
- 36.97
- V
- 3.06M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About AXGN
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
SectorNot available
IPO DateDec 17, 1986
Employees622
Stock ExchangeNasdaq
Ticker SymbolAXGN
Websitehttps://www.axogeninc.com
Key Financial Statistics
| Market Cap | $2.55B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $15.27 - $52.91 |
| 52-Week Avg Volume | 1.06M |
| VWAP | $37.88 |
| Transactions | 38,908 |
| Total Recorded Bars | 9,244 days |